Diagnosed in more than 90% of cervical cancers, the fourth deadliest cancer in women,
human papillomavirus (HPV) is currently the most common pathogen responsible for female …

Prophylactic human papillomavirus (HPV) vaccination programs constitute major public
health initiatives worldwide. We assessed the global effect of quadrivalent HPV (4vHPV) …

Background Tracking progress and providing timely evidence is a fundamental step forward
for countries to remain aligned with the targets set by WHO to eliminate cervical cancer as a …

Background The knowledge that persistent human papillomavirus (HPV) infection is the
main cause of cervical cancer has resulted in the development of prophylactic vaccines to …

Background Cervical cancer is an important global health problem. In this study we aimed to
analyze trends in cervical cancer at the global, regional, and national levels from 1990 to …

Objective To evaluate the diagnostic accuracy of high-risk human papillomavirus (hrHPV)
assays on self samples and the efficacy of self sampling strategies to reach underscreened …

Infectious diseases are caused by pathogenic microorganisms and can be transmitted
between individuals and populations thus threatening the general public health and …

Background Persistent infection with high‐risk human papillomaviruses (hrHPV) types is
causally linked with the development of cervical precancer and cancer. HPV types 16 and …

The worldwide prevalence of infection with human papillomavirus (HPV) in women without
cervical abnormalities is 11–12% with higher rates in sub-Saharan Africa (24%), Eastern …

Cervical cancer is on the declining trend in India according to the population-based
registries; yet it continues to be a major public health problem for women in India …